(HealthDay)—Adding the drug Herceptin to chemotherapy for certain breast cancer patients increases overall survival and reduces the risk of recurrence compared to chemotherapy alone, new research shows.
20 hours ago
not rated yet | 0
Scientists at Karolinska Institutet and Swansea University in Wales have, in studies in rodents and humans, identified two cholesterol-like molecules that play an important role in regulating the survival ...
Oct 09, 2014
5 / 5 (4) | 1